Estrella Immunopharma
ESLA
22 hedge funds and large institutions have $33.9M invested in Estrella Immunopharma in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
79% more capital inflows, than outflows
Capital inflows: $2.23M | Capital outflows: $1.24M
5% more funds holding
Funds holding: 21 → 22 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11.49% less ownership
Funds ownership: 69.44% → 57.95% (-11%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$2.18M |
| 2 |
OFG
OTA Financial Group
Purchase,
New York
|
+$56.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Linden Advisors
New York
|
-$1.24M |
| 2 |
Karpus Investment Management
Pittsford,
New York
|
-$1K |
ESLA Hedge Fund Activity: Q2 2022 in Review
22 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma (ESLA) for Q2 2022, worth a combined $33.9M — up 3.1% from $32.9M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ESLA positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Cubist Systematic Strategies, opening a new position worth an estimated $2.18M. The largest seller was Linden Advisors, cutting an estimated $1.24M.
- 22 institutional investors held Estrella Immunopharma (ESLA) as of Q2 2022, up from 21 in Q1 2022.
- Funds reported $33.9M of Estrella Immunopharma stock for Q2 2022, up 3.1% quarter-over-quarter.
- 1 fund opened new Estrella Immunopharma positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest Estrella Immunopharma buyer in Q2 2022 was Cubist Systematic Strategies, an estimated $2.18M added.
- The largest Estrella Immunopharma seller in Q2 2022 was Linden Advisors, an estimated $1.24M sold.
Based on aggregated 13F filings for Q2 2022.